The CEO Who Refuses to Grow His Company — and Still Runs Trials in 10 Countries
Episode 51
Andreas Beust on how a small CRO covers the globe without growing | Pharma Prescribed Andreas Beust is CEO and Managing Director of GCP Service International, a Bremen-based CRO working across medicinal products, medical devices and in vitro diagnostics. He's also President of ACROS — the Association of International CROs — and a guest lecturer at the University of Bremen. He started on the biostatistics desk. He's now running the company, elected by a leader who — not yet 50 — went looking for a successor because clinical research moves too fast to leave succession to chance. In this episode Andreas makes complex things accessible, which is his stated mission. He explains the ACROS model: ten similarly-sized, like-minded CROs from the US to Europe, the Middle East, India, China and Australia, who agree that once a partner joins, their country is off-limits to the others. It lets a small CRO run trials globally — 20 concurrent studies across Spain, Italy and Portugal through one trusted partner — without ballooning into the kind of large, rigid, expensive organisation that can't serve smaller sponsors. Grow together, not bigger. He's refreshingly frank on AI: a lot of overpromise and underdeliver, quarter-of-a-million-per-seat licence fees that no small or mid-size company can pay, and real but modest gains in medical writing, programming and knowledge capture — always human in the loop. And he's honest about the thing that actually drives growth: discomfort.
Publisher
Adam Walker’s Pharma Prescribed Podcast
Link
pharmaprescribed.podbean.com/e/andreas-beust-on-how-a-small-cro-covers-the-globe-without-growing-pharma-prescribed/
Published
August 1, 2026
Duration
52 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Adam Walker
Adam Walker’s Pharma Prescribed Podcast
@adamwalkerspharmaprescribedp
#refuses #runstrials #countries #lifesciences #management
